Cyclerion Therapeutics Inc’s recent filing unveils that its 10% Owner Slate Path Capital LP unloaded Company’s shares for reported $0.56 million on Nov 21 ’24. In the deal valued at $1.55 per share,357,880 shares were sold. As a result of this transaction, Slate Path Capital LP now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Truist initiated its Cyclerion Therapeutics Inc [CYCN] rating to a Buy in a research note published on October 20, 2021; the price target was $14. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late September with a ‘”an Overweight”‘ rating. Credit Suisse began covering CYCN with “Neutral” recommendation on June 03, 2019.
Price Performance Review of CYCN
On Tuesday, Cyclerion Therapeutics Inc [NASDAQ:CYCN] saw its stock jump 2.81% to $3.29. Over the last five days, the stock has gained 0.61%. Cyclerion Therapeutics Inc shares have fallen nearly -1.49% since the year began. Nevertheless, the stocks have risen 45.37% over the past one year. While a 52-week high of $9.47 was reached on 12/04/24, a 52-week low of $1.27 was recorded on 11/22/24. SMA at 50 days reached $2.79, while 200 days put it at $2.87.
Levels Of Support And Resistance For CYCN Stock
The 24-hour chart illustrates a support level at 3.06, which if violated will result in even more drops to 2.83. On the upside, there is a resistance level at 3.47. A further resistance level may holdings at 3.65. The Relative Strength Index (RSI) on the 14-day chart is 51.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.10%. Stochastics %K at 14.47% indicates the stock is a buying.
How much short interest is there in Cyclerion Therapeutics Inc?
A steep rise in short interest was recorded in Cyclerion Therapeutics Inc stocks on 2024-10-31, growing by 3685.0 shares to a total of 14439.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 10754.0 shares. There was a rise of 25.52%, which implies that there is a positive sentiment for the stock.
